Literature DB >> 16078087

Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.

Hans-Jürgen Möller1, Heinz Grunze, Karl Broich.   

Abstract

This conceptual review summarises the results of relevant studies on antidepressants, mood stabilisers such as lithium and anticonvulsants, and second generation antipsychotics in the indication of bipolar depression. Based on methodological and clinical considerations, the position of antidepressants and the possible alternatives in this indication are reviewed very carefully. In addition the regulatory requirements for licensing a drug for the indication "short-term treatment of bipolar depression" are described.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16078087     DOI： 10.1007/s00406-005-0591-9

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


  70 in total

Review 1.  International Consensus Group on Bipolar I Depression Treatment Guidelines.

Authors:  Joseph R Calabrese; Siegfried Kasper; Gordon Johnson; Osamu Tajima; Eduard Vieta; Lakshmi N Yatham; Allan H Young
Journal:  J Clin Psychiatry       Date:  2004-04       Impact factor: 4.384

2.  Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder.

Authors:  J R Calabrese; G A Delucchi
Journal:  Am J Psychiatry       Date:  1990-04       Impact factor: 18.112

3.  A double-blind study comparing idazoxan and bupropion in bipolar depressed patients.

Authors:  F Grossman; W Z Potter; E A Brown; G Maislin
Journal:  J Affect Disord       Date:  1999-12       Impact factor: 4.839

4.  Treatment of bipolar depression with carbamazepine: results of an open study.

Authors:  S C Dilsaver; S C Swann; Y W Chen; A Shoaib; B Joe; K J Krajewski; N Gruber; Y Tsai
Journal:  Biol Psychiatry       Date:  1996-11-01       Impact factor: 13.382

5.  Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database.

Authors:  A Khan; S R Khan; R M Leventhal; W A Brown
Journal:  Int J Neuropsychopharmacol       Date:  2001-06       Impact factor: 5.176

6.  Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database.

Authors:  A Khan; H A Warner; W A Brown
Journal:  Arch Gen Psychiatry       Date:  2000-04

Review 7.  [Lithium in the treatment of acute depression].

Authors:  M Adli; T Bschor; B Canata; S Döpfmer; M Bauer
Journal:  Fortschr Neurol Psychiatr       Date:  1998-10       Impact factor: 0.752

8.  Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin
Journal:  J Psychopharmacol       Date:  2003-06       Impact factor: 4.153

9.  A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives.

Authors:  A Bocchetta; F Bernardi; C Burrai; M Pedditzi; M Del Zompo
Journal:  Acta Psychiatr Scand       Date:  1993-12       Impact factor: 6.392

10.  Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness.

Authors:  J Mendlewicz; M B Youdim
Journal:  J Affect Disord       Date:  1980-06       Impact factor: 4.839
View more
  13 in total

Review 1.  [Problems of evidence-based medicine in psychopharmacotherapy: problems of evidence grading and of the evidence basis for complex clinical decision making].

Authors:  H-J Möller; W Maier
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

2.  Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations.

Authors:  Hans-Jürgen Möller; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02       Impact factor: 5.270

Review 3.  Is evidence sufficient for evidence-based medicine?

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-11       Impact factor: 5.270

4.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

Review 5.  Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

6.  Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan J Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-15       Impact factor: 5.270

Review 7.  [Core symptoms of depression. Effectiveness of antidepressant therapy].

Authors:  J Damm; D Eser; C Schüle; H-J Möller; R Rupprecht; T C Baghai
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

Review 8.  Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 9.  Bipolar II disorder : epidemiology, diagnosis and management.

Authors:  Franco Benazzi
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks.

Authors:  S N Ghaemi; A P Wingo; M A Filkowski; R J Baldessarini
Journal:  Acta Psychiatr Scand       Date:  2008-08-24       Impact factor: 6.392
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.